Shed GLP-1

Product Details

What Is Shed GLP-1?

Shed GLP-1 is an online prescription programme that gives eligible customers access to provider-directed GLP-1 treatment options. The microdose programme currently presents compounded semaglutide and compounded tirzepatide as treatment choices.

According to the manufacturer, the microdose approach uses lower-than-standard doses and is intended for people seeking a more gradual approach to GLP-1 treatment. A licensed provider reviews the individual’s health information and determines whether treatment is appropriate.

This is a prescription medication programme rather than a dietary supplement. Compounded medications are not FDA-approved finished drug products, and their safety, effectiveness and quality are not reviewed by the FDA in the same premarket process used for approved drugs.

Who May Consider Shed GLP-1?

Shed GLP-1 may be considered by adults interested in provider-supervised prescription treatment for weight-management goals. The manufacturer says its microdose option may also be discussed for people interested in appetite awareness, weight maintenance or broader wellness goals.

Eligibility is not automatic. A licensed provider must review the person’s health history and determine whether a particular medication and dosing plan are appropriate. Anyone experiencing persistent, unexplained or concerning symptoms should seek an appropriate medical evaluation.

How May Shed GLP-1 Support General Wellness?

Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GIP and GLP-1 receptor pathways. These hormone pathways are involved in appetite regulation, gastrointestinal activity and glucose-related processes.

The manufacturer describes its microdose programme as a lower-dose approach intended to support appetite awareness, energy, metabolic health and other wellness goals. These are manufacturer descriptions and should not be treated as independently established benefits of Shed’s specific compounded formulations.

Individual responses to prescription GLP-1 medicines can differ. The medication, dose and treatment schedule should be determined by the prescribing provider.

Supplement Facts

Shed GLP-1 is not a dietary supplement, so a conventional Supplement Facts panel does not apply.

The official portal presents two prescription treatment choices:

The exact concentration, dose, container size and inactive ingredients should be taken from the prescription and dispensing label supplied to the individual patient.

The FDA has specifically warned that compounded injectable semaglutide products can have different concentrations and that patients can encounter confusion when doses are expressed in different measurement units.

Active Ingredients

Shed’s microdose programme presents two alternative active medications; the prescribed option and dose are determined by the provider.

Semaglutide

Semaglutide is a GLP-1 receptor agonist involved in appetite and glucose regulation. The specific concentration and compounded formulation supplied through Shed are determined by the prescription and dispensing pharmacy.

Tirzepatide

Tirzepatide acts on GIP and GLP-1 receptors. The exact compounded concentration and prescribed amount supplied through Shed are not publicly disclosed on the general microdose page and should be confirmed on the dispensing label.

Potential Benefits

• May support appetite awareness: GLP-1 pathways participate in appetite regulation.
• May support weight-management goals: The programme is marketed for provider-directed weight management.
• Provides personalised treatment: The provider determines whether treatment is appropriate.
• Offers alternative medication options: The programme presents compounded semaglutide and tirzepatide.
• Provides online care: Shed describes its programme as personalised and provider-led.

These points describe the medication class or the manufacturer’s positioning. They do not guarantee a particular outcome from a compounded Shed formulation.

Important Limitations

• The specific concentration and inactive ingredients may not be publicly available before dispensing.
• Individual eligibility, dosing and treatment decisions require provider assessment.

How to Use

Because Shed GLP-1 is prescription medication, use it strictly according to the prescription and instructions supplied by the prescribing provider and dispensing pharmacy.

• Use only the medication and concentration prescribed for you.
• Follow the exact dose and frequency stated on your prescription label.
• Follow the pharmacy’s instructions for preparing and administering an injection.
• Do not independently increase, decrease or change the prescribed dose.
• Follow the dispensing pharmacy’s storage and handling instructions.

Warnings and Precautions

• Tell your healthcare provider if you are pregnant, planning pregnancy or breastfeeding.
• Tell your provider about all prescription medicines, over-the-counter medicines, vitamins and supplements you use.
• Discuss any history of pancreatic, kidney, gastrointestinal or gallbladder problems with your provider.
• Tell your provider about previous allergic or hypersensitivity reactions.
• Tell your provider if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
• Inform your healthcare professional about planned surgery or procedures requiring anaesthesia or deep sedation.
• Do not share prescription medication or injection equipment with another person.
• Keep medication away from children and follow the pharmacy’s storage instructions.

Pros

• Provider-led online prescription evaluation
• Two GLP-1 medication choices
• Personalised treatment based on provider assessment
• Online care and prescription support
• Medication delivery is available through the programme

Cons

• Specific formulation and inactive-ingredient details are not publicly disclosed.
• Prescription eligibility must be determined by a licensed provider.
• Compounded GLP-1 medicines carry medication-specific safety and dosing considerations.

Pricing and Money-Back Guarantee

Portal pricing shows two microdose options, with monthly starting prices and guarantee terms described separately.

The $149/month and $199/month figures above are the starting prices displayed in the official Shed portal screenshot supplied for this review. They should not be interpreted as a guaranteed final price for every patient or prescription.

Shed’s public microdose information states that the programme is provider-led and uses compounded injectable semaglutide or tirzepatide.

Shed’s current terms also describe a 120-Day Weight Loss Guarantee, subject to the eligibility requirements and conditions in the company’s Terms and Conditions. The guarantee should not be described as an unconditional money-back offer.

Pricing and availability were checked on 24 August 2026 and may change on the official website.

Frequently Asked Questions

What type of treatment is Shed GLP-1?

Shed GLP-1 is an online prescription programme offering compounded semaglutide or tirzepatide options. A licensed provider evaluates eligibility and determines whether a particular treatment is appropriate.

How should Shed GLP-1 be taken?

Use the medication exactly as prescribed. The dose, frequency, injection instructions and storage requirements depend on the specific compounded formulation and should come from your provider and dispensing pharmacy.

How long does one Shed GLP-1 supply last?

The duration depends on the prescription and treatment plan. The official portal displays monthly starting prices, but the exact medication quantity and supply should be confirmed with the dispensing pharmacy.

Can Shed GLP-1 be taken with prescription medication?

Potential interactions depend on your other medicines and health history. Give your prescribing provider a complete list of prescription medicines, over-the-counter products, vitamins and supplements before treatment.

Is Shed GLP-1 suitable during pregnancy or breastfeeding?

Pregnancy and breastfeeding require individual medical advice. Tell your healthcare provider about pregnancy, planned pregnancy or breastfeeding before beginning or changing a GLP-1 prescription.

Where can Shed GLP-1 be purchased?

Shed provides its programme online through its official portal. Customers complete the required health information and provider evaluation before a prescription can be issued when clinically appropriate.

Sources and Product Review Information

• Official product portal: Shed GLP-1 official portal
• Official Shed microdose information: Shed Microdose GLP-1
• Official Shed Terms and Conditions: Shed Terms and Conditions
• FDA information on compounded GLP-1 medicines: FDA: Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
• FDA compounded semaglutide dosing guidance: FDA: Dosing Errors Associated With Compounded Injectable Semaglutide
• FDA semaglutide prescribing information: FDA Wegovy Prescribing Information
• FDA tirzepatide prescribing information: FDA Zepbound Prescribing Information
• Product information checked: 24 August 2026

Affiliate Disclosure

This page may contain affiliate links. If you make a purchase through one of these links, we may earn a commission at no additional cost to you. This does not influence the information presented above, which is based on publicly available product, programme, regulatory and label information.